Strengthening fragile immune memories to fight chronic infections

	Tweet

After recovering from the flu or another acute infection, your immune system is ready to react quickly if you run into the same virus again. White blood cells called memory T cells develop during the infection and help the immune system remember the virus and attack it if it comes back.

But chronic infections such as those caused by viruses like HIV and hepatitis C are different. If the immune system can’t clear the infection out of the body fast enough, the memory T cells that initially developed against the virus upon first encounter are lost. This poses a challenge for vaccine development.

Researchers at the Emory Vaccine Center have identified the conditions that make memory T cells slip away during persistent infections. They have also shown that a molecule called 2B4 on memory cells causes them to slow down during chronic infections. The results are published online this week in the journal Immunity.

The results have implications for vaccine design. The authors emphasize the importance of having vaccines that encourage the immune system to quickly control a potentially chronic infection or prevent it from gaining a foothold – a task that some experimental vaccines against HIV’s cousin SIV have accomplished.

“In a chronic infection, the memory T cells become so tightly regulated that they eventually are ineffective,” says first author Erin West, an Emory graduate student in immunology and molecular pathogenesis. “This is why it’s so important to have that initial strength at the beginning.”

West and most of the co-authors are in the laboratory of Rafi Ahmed, PhD, director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar. Researchers from Harvard Medical School also contributed to the study, including W. Nicholas Haining and Cox Terhorst.

West and her colleagues studied mice infected by a meningitis virus which establishes a chronic infection. A weaker form of the virus can be cleared from the body in a couple weeks. They tracked naïve T cells as well as memory T cells’ responses to infections that varied in dose and persistence.

A molecule called 2B4 appears on memory T cells that are activated during chronic infections and slows them down, the Emory team found. This level of regulation probably helps control the immune system and prevents it from developing dangerous over-inflammation, West says.

“Perhaps the body says ‘I can’t take care of this, so I will shut down,’ before too much inflammation and damage occurs,” she says.

Emory researchers have identified other molecules that produce “immune exhaustion” on T cells such as PD-1, but 2B4 is different because it seems to specifically regulate memory T cells. If memory T cells are engineered to lack 2B4, they are better able to persist during a chronic infection, although it’s not clear whether the cells are then more effective at fighting the infection, West says. Blocking 2B4 might be a way to enhance immune responses against chronic infections, but more information is needed about how it works, she says.

The researchers also found that memory T cells need more “help,” in the form of signals from other T cells, in the setting of chronic infection. This is a reversal of the situation in acute infections, where memory T cells are quicker to respond and need less help, she says.

In the paper, the Emory team cites a HIV vaccine tested in Thailand that was shown to have some ability to block initial infection, and an experimental hybrid vaccine against SIV designed by scientists in Oregon that has shown similar effects. They suggest that their results could be used to tune future vaccine design efforts and take advantage of these successes.

###

The research was supported by the National Institutes of Health.

Reference: E.E. West et al. Tight Regulation of Memory CD8+ T cells Limits Their Effectiveness during Sustained High Viral Load. Immunity (posted online August 18, 2011).

The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service.

###

Contact: Holly Korschun

404-727-3990
Emory University

RELATED STORIES:
Encephalitis death toll in northern India nears 400   Pertussis vaccination recommended for teens   Bubonic plague confirmed in Los Angeles woman   UK develops bird flu tests   Polio epidemic in Africa coming under control - WHO   Pharmaceutical conservation key to slowing rise of antibiotic-resistant infections   Scientists find deadly component of 1918 flu virus   Entry point for hepatitis C infection identified   UK reports third ‘mad cow’ case from transfusion   Dramatic Rise in Hepatitis C-Related Deaths in the United States   Study shows a serious risk of side effects when having latent tuberculosis therapy over age 65   China says meningitis outbreak routine

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]